前交叉韧带修复与重建的最小临床重要差异、患者可接受症状状态及临床结局:SANTI研究组的配对分析
该配对队列研究比较前交叉韧带修复与重建至少随访2年的临床和功能结局,75对匹配患者中修复组6个月腘绳肌力量更好、FJS-12评分更高且PASS达标率更高,但再断裂率显著更高,年轻患者风险尤其高。
要点
- 修复组6个月腘绳肌力量缺损为1.7%±12.2%,重建组为-10.0%±12.8%(P<.0001)。
- 修复组再断裂率5.3%,重建组0.0%(P=.045);失败者平均年龄26.8岁 vs 未失败者40.7岁(P=.013)。
- 修复组FJS-12的PASS达标率77.3%,重建组60.0%(P=.034)。
核心结论
- 前交叉韧带修复相比重建在6个月腘绳肌力量和FJS-12评分方面具有优势,但修复后再断裂率显著更高,年轻患者风险尤其高。
研究设计与样本
- 队列研究,证据等级3级;将接受前交叉韧带修复的患者按人口学、受伤至手术时间、膝关节松弛参数、半月板损伤、术前活动水平和运动参与进行倾向性1:1匹配至同期接受前交叉韧带重建的患者。
- 共评估75对匹配患者(150例)。
主要发现
- 修复组6个月腘绳肌力量平均为1.7%±12.2%,重建组为-10.0%±12.8%(P<.0001)。
- 末次随访平均30.0±4.8个月时,修复组FJS-12平均82.0±15.1,重建组74.2±21.7(P=.017)。
- 主观IKDC评分修复组86.8±9.0 vs 重建组86.7±10.1(P<.0001),侧侧前后松弛差异修复组1.1±1.4 mm vs 重建组0.6±1.0 mm(P<.0001),修复均满足非劣效标准。
- 重返伤前运动水平比例修复组74.7% vs 重建组60.0%(P=.078),无显著差异。
- 再断裂率修复组5.3% vs 重建组0.0%(P=.045);修复失败者平均年龄26.8岁 vs 未失败者40.7岁(P=.013)。
关键数值与推荐
- 最小临床重要差异和患者可接受症状状态阈值在修复组中定义。
临床怎么用
- 前交叉韧带修复在6个月腘绳肌力量和FJS-12评分上优于重建,但再断裂率更高,年轻患者风险尤其高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There has been increasing interest in anterior cruciate ligament (ACL) repair because of theoretical advantages over ACL reconstruction; however, the contemporary literature has failed to provide high-quality evidence to demonstrate these advantages. PURPOSE: To compare the clinical and functional outcomes of ACL repair versus ACL reconstruction at a minimum follow-up of 2 years. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Patients who underwent ACL repair were propensity matched (based on demographics, time between injury and surgery, knee laxity parameters, presence of meniscal lesions, preoperative activity level, and sport participation), in a 1:1 ratio, to those who underwent ACL reconstruction during the same period. Isokinetic testing was used to evaluate strength deficits at 6 months postoperatively. Knee laxity parameters were evaluated at 12 months. Complications, return to sport, and patient-reported outcome scores were recorded at final follow-up. RESULTS: In total, 75 matched pairs (150 patients) were evaluated. The repair group had significantly better mean hamstring muscle strength at 6 months compared with the reconstruction group (1.7% ± 12.2% vs -10.0% ± 12.8%, respectively; P < .0001). At a mean final follow-up of 30.0 ± 4.8 months, the repair group had a significantly better mean Forgotten Joint Score-12 (FJS-12) score compared with the reconstruction group (82.0 ± 15.1 vs 74.2 ± 21.7, respectively; P = .017). Noninferiority criteria were met for ACL repair, compared with ACL reconstruction, with respect to the subjective International Knee Documentation Committee score (86.8 ± 9.0 vs 86.7 ± 10.1, respectively; P < .0001) and side-to-side anteroposterior laxity difference (1.1 ± 1.4 vs 0.6 ± 1.0 mm, respectively; P < .0001). No significant differences were found for other functional outcomes or the pivot-shift grade. There were no significant differences in the rate of return to the preinjury level of sport (repair group: 74.7%; reconstruction group: 60.0%; P = .078). A significant difference was observed regarding the occurrence of ACL reruptures (repair group: 5.3%; reconstruction group: 0.0%; P = .045). Patients who experienced a failure of ACL repair were significantly younger than those who did not (26.8 vs 40.7 years, respectively; P = .013). There was no significant difference in rupture rates between the repair and reconstruction groups when only patients aged >21 years were considered (2.9% vs 0.0%, respectively; P = .157). The minimal clinically important difference and Patient Acceptable Symptom State (PASS) thresholds were defined for the ACL repair group. A significantly greater proportion of patients in the repair group achieved the PASS for the FJS-12 compared with their counterparts in the reconstruction group (77.3% vs 60.0%, respectively; P = .034). CONCLUSION: ACL repair was associated with some advantages over ACL reconstruction including superior hamstring muscle strength at 6 months and significantly better FJS-12 scores. However, the failure rate was significantly higher after ACL repair, and younger patients were particularly at risk.
引用
- Ferreira A, Saithna A, Carrozzo A, et al. The Minimal Clinically Important Difference, Patient Acceptable Symptom State, and Clinical Outcomes of Anterior Cruciate Ligament Repair Versus Reconstruction: A Matched-Pair Analysis From the SANTI Study Group. Am J Sports Med. 2022. PMID: 36259683. doi:10.1177/03635465221126171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。